AzTrials
AzTrials

Acute Respiratory FailureSyncAutoVNINCT03787173

Patient-ventilator Synchronisation Study for Intensive Care Unit Patients

A study testing Optimized and Automated in people with Acute Respiratory Failure, run by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This cross-over study will compare the asynchrony index between standard manual ventilator settings, optimized manual ventilator settings, and automated ventilator setting in intensive care patients ventilated in non-invasive ventilation with a high asynchrony index. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Acute Respiratory Failure
What is being tested?
Optimized and Automated
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteFrance
Study dates
17 Apr 2019to 16 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient aged over 18 years old
  • Covered by social insurance
  • Consent for study signed by patient or next-of-kin
  • NIV session indicated for at least 2 hours
  • Asynchrony index ≥ 30% with standard manual settings

Who cannot join

  • Patient requiring continuous NIV
  • Contra-indication to esophageal catheter insertion: gastric ulcer, esophageal varices, pharyngeal or laryngeal tumor.
  • Patient with withholding decision about intubation
  • Moribund patient
  • Patient included in another interventional study in the last 30 days
  • Patient that does not speak French
  • Pregnant women

Trial locations and contacts

1 site in 1 country.

France1 site
  • Centre Hospitalier Intercommunal Toulon La Seyne sur Mer

    Toulon, Var, 83056

Other trials in France

About this study

Official title: Patient-ventilator Synchronisation Study in Non Invasive Ventilation for Intensive Care Unit Patients: Comparison Between Manual and Automated Ventilator Settings.

This cross-over study will compare the asynchrony index between standard manual ventilator settings, optimized manual ventilator settings, and automated ventilator setting in intensive care patients ventilated in non-invasive ventilation with a high asynchrony index. The hypothesis is that both manual optimized ventilator settings and automated ventilator settings are associated with a lower patient-ventilator asynchrony index as compared to manual standard ventilator settings.

A randomized cross-over design method will be used. Patient requiring NIV with an asynchrony index over 35% will be included. An esophageal catheter with a balloon will be inserted to monitor esophageal pressure. Patients will be ventilated during 3 periods of 30 min, with 10 minutes of washout in between. Recordings of airway pressure, airway flow, and esophageal pressure will be analyzed by two investigators blinded of the trigger settings.

The primary outcome will be the asynchrony index. The secondary outcome will be the ineffective inspiratory effort index, autotrigering index, double triggering index, inspiratory trigger delay, cycling delay, total time spent in asynchrony, patient comfort, and blood gas results.

Read the detailed description

Non-invasive ventilation (NIV) is used in 35% of patient admitted in intensive care unit (ICU) with a failure rate of 10 to 70% depending on the indication and clinician experience. Patient-ventilator asynchrony is a frequent cause of NIV failure. Therefore, optimizing patient-ventilator synchronization is important for its comfort, tolerance, and efficacy. An optimal patient-ventilation is achieved when the mechanical breath provided by the ventilator match the patient inspiratory effort. The ratio between the number of asynchronies divided by the number of patient inspiratory effort define the asynchrony index (AI). AI over 10% is considered as severe and occurs in 30 to 43% of patients ventilated in NIV. Patient ventilator asynchronies occurs because ventilator settings of inspiratory and expiratory triggers remain constant in patient with variable respiratory drive, and unintentionnals leaks that are difficult to control in NIV. Thus using an automatic adjustment of inspiratory and expiratory triggers setting according to patient effort and unintentional leaks may decrease the number of patient-ventilator asynchronies. This cross-over study will compare the asynchrony index between standard manual ventilator settings, optimized manual ventilator settings, and automated ventilator setting in intensive care patients ventilated in non-invasive ventilation with a high asynchrony index. The hypothesis is that both manual optimized ventilator settings and automated ventilator settings are associated with a lower patient-ventilator asynchrony index as compared to manual standard ventilator settings.

A randomized cross-over design method will be used. Patient requiring NIV with an asynchrony index over 30% will be included. An esophageal catheter with a balloon will be inserted to monitor esophageal pressure. Patients will be ventilated during 3 periods of 30 min, with 10 minutes of washout in between. Recordings of airway pressure, airway flow, and esophageal pressure will be analyzed by two investigators blinded of the trigger settings.

The primary outcome will be the asynchrony index. The secondary outcome will be the ineffective inspiratory effort index, autotrigering index, double triggering index, inspiratory trigger delay, cycling delay, total time spent in asynchrony, patient comfort, and blood gas results.

The sample size was calculated from the total asynchrony index (primary outcome). Patients with an asynchrony index over 30% in using manual standard ventilator settings will be included. Considering an asynchrony index of 30 ± 15 % in manual standard ventilator settings with a clinically significant objective to reduce the asynchrony index to 15% in manual optimized ventilator settings and automated ventilator settings, a sample size of 30 patients is required with a risk at 0.05 and a power at 80%. Therefore, 35 patients are planned.

Being tested
Optimized, Automated
Keywords
non invasive ventilation, patient ventilator synchrony, acute respiratory failure, closed loop ventilation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • OptimizedDevice

    Inspiratory trigger and Expiratory trigger settings optimized by investigator

  • AutomatedDevice

    Inspiratory trigger and Expiratory trigger settings automatized

Study groups in NCT03787173
Study groupRoleWhat they receive
Manual standard ventilator settingsNo interventionInspiratory trigger set at 2 l/min, Expiratory trigger set at 25% of peak inspiratory flow
Manual optimized ventilator settingsActive comparatorInspiratory trigger and Expiratory trigger settings optimized by investigator
Receives: Device: Optimized
Automated ventilator settingsExperimentalInspiratory trigger and Expiratory trigger settings automatized
Receives: Device: Automated

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Asynchrony index

    Ratio between the total number of asynchronies divided by the number of patient inspiratory effort

    Measured: Continuous measurement over 30min

Secondary outcomes (10)
  1. Lineffective inspiratory effort index

    Ratio between the total number of ineffective inspiratory effort divided by the number of patient inspiratory effort

    Measured: Continuous measurement over 30min

  2. Autotrigering index

    Ratio between the total number of autotriggered breath divided by the number of patient inspiratory effort

    Measured: Continuous measurement over 30min

  3. Double triggering index

    Ratio between the total number of double triggered breath divided by the number of patient inspiratory effort

    Measured: Continuous measurement over 30min

  4. Inspiratory trigger delay

    Time between the beginning of patient effort assessed on oesophageal pressure and beginning of mechanical breath.

    Measured: Continuous measurement over 30min

  5. Cycling delay

    Time between the end of patient effort assessed on oesophageal pressure and the end of mechanical breath.

    Measured: Continuous measurement over 30min

  6. Total time spent in asynchrony

    Ratio of total time of ineffective inspiratory effort, inspiratory trigger delay, and cycling delay on total time of recording.

    Measured: Continuous measurement over 30min

  7. Patient comfort

    Visual analog scale of Likert type measuring patient comfort going from 0 (very uncomfortable) to 10 (very comfortable)

    Measured: 1 day (Single measurement)

  8. Blood PaO2 results

    PaO2

    Measured: After each period at 30 min, 1 h and 1 h 30 min

  9. Blood PaCO2 results

    PaCO2

    Measured: After each period at 30 min, 1 h and 1 h 30 min

  10. Blood pH results

    pH

    Measured: After each period at 30 min, 1 h and 1 h 30 min

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Dec 2018
  2. Study start17 Apr 2019
  3. Primary completion16 Apr 2024
  4. Study completion16 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03787173
Sponsor's protocol ID
2018-CHITS-01
Other IDs
2018-A00658-47
Acronym
SyncAutoVNI
Status last verified
Jan 2025
First submitted
20 Dec 2018
Last updated
28 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Demoule A, Chevret S, Carlucci A, Kouatchet A, Jaber S, Meziani F, Schmidt M, Schnell D, Clergue C, Aboab J, Rabbat A, Eon B, Guerin C, Georges H, Zuber B, Dellamonica J, Das V, Cousson J, Perez D, Brochard L, Azoulay E; oVNI Study Group; REVA Network (Research Network in Mechanical Ventilation). Changing use of noninvasive ventilation in critically ill patients: trends over 15 years in francophone countries. Intensive Care Med. 2016 Jan;42(1):82-92. doi: 10.1007/s00134-015-4087-4. Epub 2015 Oct 13.

    PubMed 26464393
  • Demoule A, Girou E, Richard JC, Taille S, Brochard L. Increased use of noninvasive ventilation in French intensive care units. Intensive Care Med. 2006 Nov;32(11):1747-55. doi: 10.1007/s00134-006-0229-z. Epub 2006 Jun 24.

    PubMed 16799775
  • Keenan SP, Sinuff T, Burns KE, Muscedere J, Kutsogiannis J, Mehta S, Cook DJ, Ayas N, Adhikari NK, Hand L, Scales DC, Pagnotta R, Lazosky L, Rocker G, Dial S, Laupland K, Sanders K, Dodek P; Canadian Critical Care Trials Group/Canadian Critical Care Society Noninvasive Ventilation Guidelines Group. Clinical practice guidelines for the use of noninvasive positive-pressure ventilation and noninvasive continuous positive airway pressure in the acute care setting. CMAJ. 2011 Feb 22;183(3):E195-214. doi: 10.1503/cmaj.100071. Epub 2011 Feb 14. No abstract available.

    PubMed 21324867
  • Ferrer M, Valencia M, Nicolas JM, Bernadich O, Badia JR, Torres A. Early noninvasive ventilation averts extubation failure in patients at risk: a randomized trial. Am J Respir Crit Care Med. 2006 Jan 15;173(2):164-70. doi: 10.1164/rccm.200505-718OC. Epub 2005 Oct 13.

    PubMed 16224108
  • El-Solh AA, Aquilina A, Pineda L, Dhanvantri V, Grant B, Bouquin P. Noninvasive ventilation for prevention of post-extubation respiratory failure in obese patients. Eur Respir J. 2006 Sep;28(3):588-95. doi: 10.1183/09031936.06.00150705. Epub 2006 May 31.

    PubMed 16737982

Questions about this trial

What is this clinical trial studying?

A study testing Optimized and Automated in people with Acute Respiratory Failure, run by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Asynchrony index (time frame: Continuous measurement over 30min). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03787173, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in